PBH
NYSE · Pharmaceuticals
Prestige Consumer Healthcare
$46.05
+0.59 (+1.30%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-26.71%
1Y
-45.61%
YTD
-24.78%
Open$46.16
Previous Close$45.46
Day High$46.39
Day Low$45.23
52W High$85.29
52W Low$42.62
Volume—
Avg Volume722.4K
Market Cap2.23B
P/E Ratio11.69
EPS$3.91
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$64.04
Below
SMA 200
$69.15
Below
RSI (14)
68.6
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Buy
10 analysts
Price Target
+69.7% upside
Current
$46.05
$46.05
Target
$78.15
$78.15
$50.25
$78.15 avg
$108.25
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.06B | 1.07B | 462.83M |
| Net Income | 185.04M | 168.50M | 138.88M |
| Profit Margin | 17.5% | 16.6% | 30.0% |
| EBITDA | 321.21M | 308.76M | 217.92M |
| Free Cash Flow | — | — | 109.94M |
| Rev Growth | -1.2% | -1.2% | +15.0% |
| Debt/Equity | 0.54 | 0.54 | 0.82 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |